Lataa...
Preclinical evaluation of afatinib (BIBW2992) in esophageal squamous cell carcinoma (ESCC)
Esophageal squamous cell carcinoma (ESCC) is the eighth most common cancer worldwide. Epidermal growth factor receptors (EGFR) are often overexpressed in esophageal cancers, thus anti-EGFR inhibitors have been evaluated in ESCC. Afatinib was an irreversible inhibitor of these ErbB family receptors....
Tallennettuna:
| Julkaisussa: | Am J Cancer Res |
|---|---|
| Päätekijät: | , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
e-Century Publishing Corporation
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4731633/ https://ncbi.nlm.nih.gov/pubmed/26885448 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|